• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Biogen Licenses CEVEC AAV Mfg. Technology contractpharma
    January 11, 2021
    Biogen gains rights to ELEVECTA Technology for manufacturing of gene therapy products.
  • CEVEC, Roche Ink ELEVECTA Technology License Agreement contractpharma
    November 12, 2020
    ​CEVEC Pharmaceuticals GmbH (CEVEC) signed an option and license agreement with Roche for the use of its newly launched ELEVECTA Technology for large scale manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service